Align Technology, US0162551016

Align Technology stock falls 1.72 percent on Nasdaq

Published on 09/25/2026 at 13:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Align Technology stock reported Q2 revenue of USD 1,056.2 million, up 4.3 percent year over year. Q3 guidance is USD 1.00 billion to USD 1.02 billion.

Moderne Zahnarztpraxis mit 3D-Intraoral-Scanner, digitale Kieferorthopädie
Align Technology Inc. NASDAQ moderne Zahnarztpraxis mit digitalem 3D-Intraoral-Scanner und Kieferorthopädie-Technologie US0162551016, Illustration mit AI erstellt.

Align Technology stock (ISIN US0162551016) fell 1.72 percent to a closing price of USD 145.62 on Nasdaq on September 24, 2026, leaving the shares 27.35 percent below the 52-week high of USD 200.44. The dated market picture puts the company between a fresh quarterly growth signal and a more restrained near-term revenue outlook.

Q2 growth meets a softer guide

According to StockTitan in the July 29, 2026 filing, Q2 2026 revenue reached USD 1,056.2 million, up 4.3 percent year over year and 1.5 percent sequentially. GAAP diluted EPS was USD 1.51, while GAAP operating margin was 14.6 percent.

The product mix explains the contrast. Clear Aligner revenue rose 8.2 percent year over year to USD 870.9 million on 691,800 shipments, while Imaging Systems and CAD/CAM Services revenue declined 10.8 percent to USD 185.3 million, according to StockTitan.

Guidance sets the near term

For Q3 2026, Align guided to worldwide revenue of USD 1.00 billion to USD 1.02 billion, compared with the Zacks consensus estimate of USD 1.01 billion. Zacks also reported that Q2 non-GAAP EPS of USD 2.64 beat its consensus estimate by 3.1 percent, while revenue topped consensus by 0.4 percent.

That comparison leaves the next quarter as the key operating checkpoint: management's midpoint of USD 1.01 billion matches the consensus figure, while the guidance range preserves downside and upside around that level. For full-year 2026, management maintained a revenue-growth target of 3 percent to 4 percent, according to Zacks.

Consensus target stays above market

MarketBeat reported a Moderate Buy consensus from 15 brokerages on September 11, 2026, with an average 12-month price target of USD 206.3571. That target stood 41.71 percent above the September 24 closing price of USD 145.62.

Closing price marks the daily move

Align Technology's September 24, 2026 closing price was USD 145.62 on Nasdaq, down USD 2.54 from the prior close of USD 148.17. The session volume was 779,772 shares, and market capitalization stood at USD 10,429,389,744.

Align Technology market snapshot

  • Company: Align Technology, Inc.
  • ISIN: US0162551016
  • Ticker: ALGN
  • Trading venue: Nasdaq
  • Price (as of September 24, 2026): Closing price USD 145.62
  • Market capitalization: USD 10,429,389,744 (as of September 24, 2026)
  • 52-week range: USD 122-200.44 (as of September 24, 2026)
  • Sector / Industry: Healthcare / Medical Devices

More news and analyses on Align Technology stock

Disclaimer...

en | US0162551016 | ALIGN TECHNOLOGY | boerse | 70183541 | bgmi